|Bid||109.28 x 100|
|Ask||110.39 x 100|
|Day's Range||109.85 - 110.27|
|52 Week Range||79.12 - 112.97|
|PE Ratio (TTM)||22.14|
|Dividend & Yield||1.80 (1.64%)|
|1y Target Est||N/A|
Weak revenue per requisition performance and reimbursement pressure might dampen Quest Diagnostics' (DGX) benefits from esoteric testing business, infectious disease testing and prescription drug monitoring business growth.
There’s something uniquely American about the heat of summer; it’s also a great time to pour some money into some US-based stocks
While the revised American Health Care Act now only needs the Senate's nod, the scenario is getting increasingly challenging for the Medical Device Space.